Activity of a novel PDGF beta-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma

Experimental Cell Research
Masaharu KanekoK Funa

Abstract

PDGF acts as an autocrine and paracrine factor in certain tumors through upregulation of the PDGF beta-receptor expression. In order to elucidate the control mechanism for the receptor expression, we have isolated an enhancer from two P1 clones that together contain a 102 kb NotI region covering the entire human PDGFRB gene. They were partially digested with TspI and cloned into the PDGFRB enhancer trap vector to make a library for identification of enhancers. The digested DNA containing enhancer was identified by expression of GFP when transfected in PDGF beta-receptor expressing cells. One of the enhancer clones was further examined by making several deletion mutants in a luciferase vector. This enhancer was most active in neuroblastoma cells, IMR32 and BE2, but less active in hemangioma and in smooth muscle cell lines. Chip assay revealed that SP1, AP2, and GATA2 bound the enhancer in BE2 cells. Their interaction occurred dependently of the cell cycle and synchronously with their binding to the promoter. Transfection of GATA2 alone or with Ets, which binds adjacent to GATA, resulted in differentiation of BE2 cells in parallel with increased PDGF beta-receptor expression. Furthermore, over-expression of the PDGF beta-receptor...Continue Reading

References

Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A SmitsK Funa
May 5, 1995·Biochemical and Biophysical Research Communications·A E BallagiK Funa
Aug 1, 1993·The European Journal of Neuroscience·A SmitsK Funa
Feb 1, 1993·Proceedings of the Society for Experimental Biology and Medicine·M C Simon
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·T NottoliT Williams
Oct 3, 1999·Physiological Reviews·C H Heldin, B Westermark
May 18, 2001·Trends in Cell Biology·A Ostman, F D Böhmer
Feb 8, 2002·Archives of Biochemistry and Biophysics·Carl-Henrik HeldinArne Ostman
Aug 3, 2002·Molecular Biology Reports·C MolanderK Funa
Jun 5, 2003·Cancer Cell·Kristian PietrasArne Ostman
Jan 13, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Joyce K DivineTheodore C Simon
Jun 23, 2004·Cytokine & Growth Factor Reviews·Christer Betsholtz
Aug 27, 2004·Development·Konstantina TsarovinaHermann Rohrer
Jan 22, 2005·Seminars in Cell & Developmental Biology·John B E Burch
Jul 23, 2005·The EMBO Journal·Ricardo L A SilvaStephen X Skapek

❮ Previous
Next ❯

Citations

Jun 18, 2014·The Journal of Clinical Investigation·Erik H KnelsonGerard C Blobe
Feb 9, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angela L GaviglioGerard C Blobe

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.